TIFFANY SIPE: Open Payments
NPI 1174848303 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,547 in 145 payments from 42 companies in 2025. Trend: 2023 $13,557 · 2024 $19,621 · 2025 $9,547
Speaker / faculty: $5,270Food & beverage: $3,363Travel & lodging: $894Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $6,414 |
| E.R. Squibb & Sons, L.L.C. | 17 | $337 |
| Incyte Corporation | 8 | $204 |
| Novartis Pharmaceuticals Corporation | 10 | $183 |
| Daiichi Sankyo Inc. | 6 | $153 |
| Caris MPI, Inc. | 4 | $152 |
| Iovance Biotherapeutics, Inc. | 2 | $145 |
| Merck Sharp & Dohme LLC | 5 | $124 |
| AstraZeneca Pharmaceuticals LP | 4 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
Products named: RYBREVANT, OPDIVO, MI CANCER SEEK, Amtagvi, KISQALI, REBLOZYL, BREYANZI, MONJUVI.
Industry payments across TN — which companies pay providers there.
